208 related articles for article (PubMed ID: 14997058)
41. Gene testing to predict tamoxifen-induced hot flashes: new biological insights.
Crandall CJ
J Clin Oncol; 2008 Dec; 26(36):5841-2. PubMed ID: 19018077
[No Abstract] [Full Text] [Related]
42. Making sense of the evidence regarding nonhormonal treatments for hot flashes.
Barton D; Loprinzi CL
Clin J Oncol Nurs; 2004 Feb; 8(1):39-42. PubMed ID: 14983762
[TBL] [Abstract][Full Text] [Related]
43. [Effect of shugan liangxue compound for relieving hot flashes in breast cancer patients].
Sun H; Xue D; Gao F
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Jan; 29(1):30-3. PubMed ID: 19338149
[TBL] [Abstract][Full Text] [Related]
44. Impact of Acupuncture on Hot Flashes in Breast Cancer Patients Receiving Adjuvant Antiestrogen Therapy with Tamoxifen: A Randomized Controlled Trial.
Jeong YJ; Choi HR; Kim KS; Shin IH; Park SH
J Integr Complement Med; 2023 Apr; 29(4):241-252. PubMed ID: 36787483
[No Abstract] [Full Text] [Related]
45. A hot flash on tamoxifen metabolism.
Goetz MP; Loprinzi CL
J Natl Cancer Inst; 2003 Dec; 95(23):1734-5. PubMed ID: 14652227
[No Abstract] [Full Text] [Related]
46. Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer.
Quella SK; Loprinzi CL; Sloan J; Novotny P; Perez EA; Burch PA; Antolak SJ; Pisansky TM
J Urol; 1999 Jul; 162(1):98-102. PubMed ID: 10379749
[TBL] [Abstract][Full Text] [Related]
47. Gabapentin vs. low-dose transdermal estradiol for treating post-menopausal women with moderate to very severe hot flushes.
Aguirre W; Chedraui P; Mendoza J; Ruilova I
Gynecol Endocrinol; 2010 May; 26(5):333-7. PubMed ID: 20050764
[TBL] [Abstract][Full Text] [Related]
48. Tolerability profile of SERMs.
Agnusdei D; Iori N
J Endocrinol Invest; 1999 Sep; 22(8):641-5. PubMed ID: 10532252
[No Abstract] [Full Text] [Related]
49. Treating hot flashes with drugs.
Harv Womens Health Watch; 2000 Aug; 7(12):7. PubMed ID: 10927663
[No Abstract] [Full Text] [Related]
50. Treating recurrent postmenopausal vasomotor symptoms in a patient with a positive family history for breast cancer.
Leong C; Lake J
Consult Pharm; 2015 Jan; 30(1):38-44. PubMed ID: 25591030
[TBL] [Abstract][Full Text] [Related]
51. Gabapentin for the management of hot flushes: a case series.
Albertazzi P; Bottazzi M; Purdie DW
Menopause; 2003; 10(3):214-7. PubMed ID: 12792292
[TBL] [Abstract][Full Text] [Related]
52. Effect of L-methionine on hot flashes in postmenopausal women: a randomized controlled trial.
Guttuso T; McDermott MP; Ng P; Kieburtz K
Menopause; 2009; 16(5):1004-8. PubMed ID: 19407666
[TBL] [Abstract][Full Text] [Related]
53. Treating hot flashes with drugs: an update.
Harv Womens Health Watch; 2002 Aug; 9(12):6. PubMed ID: 12370152
[No Abstract] [Full Text] [Related]
54. Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis.
Loprinzi CL; Sloan J; Stearns V; Slack R; Iyengar M; Diekmann B; Kimmick G; Lovato J; Gordon P; Pandya K; Guttuso T; Barton D; Novotny P
J Clin Oncol; 2009 Jun; 27(17):2831-7. PubMed ID: 19332723
[TBL] [Abstract][Full Text] [Related]
55. Hot flashes. A closer look at causes and remedies.
Mayo Clin Womens Healthsource; 2003 Apr; 7(4):1-2. PubMed ID: 12660601
[No Abstract] [Full Text] [Related]
56. Cimicifuga racemosa for the treatment of hot flushes in women surviving breast cancer.
Hernández Muñoz G; Pluchino S
Maturitas; 2003 Mar; 44 Suppl 1():S59-65. PubMed ID: 12609560
[TBL] [Abstract][Full Text] [Related]
57. Clinical Inquiry: Do venlafaxine and gabapentin control hot flashes in women with a history of breast cancer?
Sarkissian A; Neher JO; Singh R; St Anna L
J Fam Pract; 2012 Dec; 61(12):759-72. PubMed ID: 23313996
[TBL] [Abstract][Full Text] [Related]
58. Gabapentin for the management of hot flashes in prostate cancer survivors: a longitudinal continuation Study-NCCTG Trial N00CB.
Moraska AR; Atherton PJ; Szydlo DW; Barton DL; Stella PJ; Rowland KM; Schaefer PL; Krook J; Bearden JD; Loprinzi CL
J Support Oncol; 2010; 8(3):128-32. PubMed ID: 20552926
[TBL] [Abstract][Full Text] [Related]
59. Estrogen receptor genotypes influence hot flash prevalence and composite score before and after tamoxifen therapy.
Jin Y; Hayes DF; Li L; Robarge JD; Skaar TC; Philips S; Nguyen A; Schott A; Hayden J; Lemler S; Storniolo AM; Flockhart DA; Stearns V
J Clin Oncol; 2008 Dec; 26(36):5849-54. PubMed ID: 19018086
[TBL] [Abstract][Full Text] [Related]
60. Effect of selective estrogen receptor modulators on reproductive tissues other than endometrium.
Hendrix SL; McNeeley SG
Ann N Y Acad Sci; 2001 Dec; 949():243-50. PubMed ID: 11795359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
